With a portfolio of 350+ companies across the health IT, medical device and bio-pharmaceutical sectors, BioEnterprise has generated XXX in investment and XXX in returns since XXXX.
With an entirely healthcare-focused team of executives-in-residence and other advisors, BioEnterprise helps startups uncover new sources of growth capital, access top talent, create effective business strategy and forge new partnerships. Through a shared vision with partner institutions, including Cleveland Clinic, University Hospitals, Case Western Reserve University and The MetroHealth System, BioEnterprise is expanding the region’s bioscience industry, creating regional jobs and making Cleveland a national leader in healthcare innovation.
Developer of regenerative medicines to treat multiple sclerosis. Raised $13M in growth capital since 2017 with on-loan BioEnterprise employees to fuel growth. In 2019, entered strategic partnership with Genentech with an option to acquire.
Drug development acceleration partner to UH Harrington Discovery Institute within Harrington Project for Discovery and Development. Launched at BioEnterprise Incubator, with $145M in growth capital raised to date and a recently announced partnership with pharmaceutical giant Bristol-Myers Squibb.
Invented a non-invasive mapping technology for electrical disorders of the heart in 2004, commercialized by CWRU researchers. Raised $37M in growth capital before being acquired by Medtronic in 2015.